Alpha Cubed Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Alpha Cubed Investments’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,355	Closed	-$210K	–	269
2019 Q2	$210K	Hold	6,355	–	–	0.02%	232
2019 Q1	$223K	Hold	6,355	–	–	0.03%	215
2018 Q4	$211K	Sell	6,355 -3,157	-33%	-$136K	0.03%	197
2018 Q3	$458K	Buy	9,512 +3,157	+50%	+$156K	0.05%	174
2018 Q2	$380K	Buy	6,355 +5	+0.1%	+$259	0.05%	146
2018 Q1	$291K	Hold	6,350	–	–	0.04%	174
2017 Q4	$253K	Hold	6,350	–	–	0.03%	203
2017 Q3	$254K	Buy	+6,350	New	+$275K	0.04%	187

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Alpha Cubed Investments's SUPN Position: Q3 2019 in Review

Alpha Cubed Investments sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 6,355 shares — an estimated $210K sold.

Alpha Cubed Investments first reported a position in SUPN in Q3 2017 and held it in 8 quarters. The position peaked at $458K in Q3 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

Alpha Cubed Investments reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Alpha Cubed Investments sold 6,355 Supernus Pharmaceuticals shares in Q3 2019, an estimated $210K.
Alpha Cubed Investments first reported a position in Supernus Pharmaceuticals in Q3 2017 and held it in 8 quarters.
Alpha Cubed Investments's Supernus Pharmaceuticals position peaked at $458K in Q3 2018.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Alpha Cubed Investments's 13F filing for Q3 2019, filed 18 Oct 2019.